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Biological effectiveness of 
accelerated protons for chromosome 
exchanges
Kerry A. George1* , Megumi Hada1 and Francis A. Cucinotta2
1 Wyle Science, Technology and Engineering Group, Houston, TX, USA, 2 University of Nevada Las Vegas, Las Vegas,  
NV, USA
We have investigated chromosome exchanges induced in human cells by seven differ-
ent energies of protons (5–2500 MeV) with LET values ranging from 0.2 to 8 keV/μm. 
Human lymphocytes were irradiated in vitro and chromosome damage was assessed 
using three-color fluorescence in situ hybridization chromosome painting in chemically 
condensed chromosomes collected during the first cell division post irradiation. The 
relative biological effectiveness (RBE) was calculated from the initial slope of the dose–
response curve for chromosome exchanges with respect to low dose and low dose-rate 
γ-rays (denoted as RBEmax), and relative to acute doses of γ-rays (denoted as RBEγAcute). 
The linear dose–response term was similar for all energies of protons, suggesting that 
the decrease in LET with increasing proton energy was balanced by the increase in 
dose from the production of nuclear secondaries. Secondary particles increase slowly 
above energies of a few hundred megaelectronvolts. Additional studies of 50  g/cm2 
aluminum shielded high-energy proton beams showed minor differences compared 
to the unshielded protons and lower RBE values found for shielded in comparison to 
unshielded beams of 2 or 2.5 GeV. All energies of protons produced a much higher 
percentage of complex-type chromosome exchanges when compared to acute doses 
of γ-rays. The implications of these results for space radiation protection and proton 
therapy are discussed.
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inTrODUcTiOn
The study of the biological effectiveness of accelerated proton exposures is of interest for clinical 
treatment plans and for assessing normal tissue damage from protons of various energies that are 
generated outside of the Bragg peak during proton therapy (1–4). Protons are also a concern for 
space radiation exposures to astronauts because the space radiation flux is predominantly energetic 
protons or secondary protons produced in nuclear interactions (5–7). Although evidence now 
indicates that relative biological effectiveness (RBE) varies considerably along the proton depth-
dose distribution, RBE modeling in treatment planning still involves significant uncertainties and, 
consequently, clinical proton therapy is usually based on the use of a generic RBE of 1.1 (4). Further 
experimental data are required before a consensus can be reached on weighting factors across the 
depth-dose profile and for different tissue effects.
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Experimental studies have shown that the RBE of protons 
varies with biological endpoint, tissue type, dose, and energy of 
the protons. RBE values calculated by cell killing and mutation 
induction indicate that low energy protons are significantly 
higher than unity and values are LET dependent (8). Published 
data on chromosome damage have indicated that RBEs or RBEmax 
values for protons of energies above 10  MeV vary from <1 to 
about 2 in comparison to X-rays or γ-rays, whereas lower energy 
protons (<10 MeV) were significantly higher than unity and the 
values were LET dependent (9–11). RBEs for tumor induction 
were close to 1 in several studies (12, 13), and as high as 2 for 
Harderian gland tumors (14) and for rat mammary carcinomas 
(15) that were induced by 250  MeV protons. The choice of 
reference radiation can complicate the analysis of RBE because 
differences have been found for X-rays and γ-rays (16), and vari-
ability has been reported for low doses of photons and protons. 
In addition, high-energy protons induce nuclear spallation and 
other interactions that produce secondary protons, neutrons, and 
heavy ion fragments. Nuclear interaction cross sections generally 
increase with the energy of the protons (3), and the secondary 
particles typically have higher LET values that can increase RBE.
In the present study, we considered the induction of simple 
and complex-type chromosome exchanges in normal human 
lymphocytes. Chromosome exchanges, especially translocations, 
are positively correlated with many cancers, and are therefore 
a potential biomarker of cancer risk associated with radiation 
exposure (17–19). In addition, RBE factors for chromosome 
aberrations are similar to RBEs observed for induction of solid 
tumors in mice (16, 20, 21). Therefore, chromosome exchanges 
are a useful biomarker for cancer risk and can be compared 
with other biomarkers in the absence of human data for galactic 
cosmic rays (GCR). In earlier work (22), we considered the effects 
of 250  MeV protons at different dose-rates. Here, we consider 
several proton energies from 5 to 2500 MeV with additional stud-
ies on the effects of heavy aluminum and polyethylene shielding 
for the high-energy proton exposures.
MaTerials anD MeThODs
These studies were conducted in accordance with accepted 
ethical and humane practices, and were approved by the appro-
priate institutional and/or governmental committee(s) and/or 
organization(s).
irradiation
Whole blood was collected from healthy volunteers and was 
irradiated with accelerated protons using the NASA Space 
Radiation Laboratory (NSRL) facility at Brookhaven National 
Laboratory (BNL). The same volunteer donated the blood 
samples for each experiment. All samples were exposed in the 
plateau portion of the Bragg curves and dose rates were between 
0.2 and 0.5  Gy/min, depending on the dose delivered. Doses 
were measured at the target using ionization chambers. Samples 
were exposed at room temperature. Each sample received at 
least three pulses and no exposure lasted more than 10 min. The 
beam uniformity was checked using a digital beam imager and 
dose did not vary more than 5% over the target area. For the 
2.5 and 2 GeV protons exposures, the target areas was shielded, 
respectively, with 50 g/cm2 of aluminum and 50 g/cm2 of alu-
minum plus 10 cm of polyethylene. At these proton energies, 
the dose increases as the protons pass through the shielding due 
to secondary radiation, and doses were normalized using BNL 
dosimetry to generate the same total dose to the sample as the 
unshielded studies.
cell culture
Immediately after exposure, whole-blood cultures in RPMI 1640 
medium (Gibco BRL) supplemented with 20% calf serum and 
1% phytohemagglutinin (Gibco, BRL) were incubated at 37°C 
for 48–50 h. Chemically induced PPC were collected using the 
method described by Durante et al. (23), which results in well-
condensed chromosomes from cells in G2 and metaphase. Briefly, 
50 nM calyculin A (Wako Chemicals) was added to the growth 
medium for the last 30 min of the incubation. Cells were then 
treated with hypotonic KCl (0.075M) for 15 min at 37°C and fixed 
in methanol:acetic acid (3:1). A 0.5 ml volume of blood from each 
sample was cultured with 10  μm bromodeoxyuridine (BrdU), 
and a differential replication staining procedure was completed 
on chromosomes from these samples by incubating slides in 
0.5  mg/ml of Hoechst during exposure to black light (General 
Electric 15T8/BL bulb). Chromosomes were stained with Giemsa 
to visualized replication rounds, revealing the percentage of cells 
in first mitosis was >95% for all samples analyzed.
Fluorescence In situ hybridization
Chromosomes were dropped onto clean microscope slides and 
hybridized in  situ with a combination of fluorescence whole-
chromosome probes for chromosomes 1, 2, and 4, or chromo-
some 1, 2, and 5 (Rainbow Scientific) using the procedures 
recommended by the manufacturer. Chromosome 1 was painted 
with a Texas red fluorophore, chromosome 2 was painted with 
FTIC, and chromosome 4 (or 5) was painted with a 1:1 combi-
nation of Texas Red and FITC that appeared yellow under the 
triple-band-pass filter set. Unlabeled chromosomes were always 
counterstained with 4′,6-diamidino-2-phenylindole (DAPI).
chromosome analysis
Chromosomes were analyzed on a Zeiss Axioplan fluorescence 
microscope. The images of all damaged cells were captured elec-
tronically using a Sensys charge-coupled device (CCD) camera 
(Photometrics Ltd., AZ, USA) and the Cytovision computer soft-
ware. The number of cells analyzed for each sample varied, exact 
numbers are listed in Table 1. All slides analyzed in this study 
were coded and scored blind. Complex exchanges were scored 
when it was determined that an exchange involved a minimum 
of three breaks in two or more chromosomes (24). An exchange 
was defined as simple if it appeared to involve two breaks in two 
chromosomes, that is, dicentrics and translocations. Incomplete 
translocations and incomplete dicentrics were included in the 
category of simple exchanges, assuming that in most cases the 
reciprocal fragments were below the level of detection (25). 
Each type of exchange – dicentrics, apparently simple reciprocal 
exchanges, incompletes, or complex exchanges  –  was counted 
as one exchange, and values for total exchanges were derived by 
TaBle 1 | Dose–response data for chromosome aberrations per 100 
cells induced by 5 different energies of protons measured in first post 
irradiation chemically induced Pcc.
Dose (gy) cells  
scored
simple  
exchanges
complex  
exchanges
e = 5 MeV
0.10 1018 2.3 ± 0.7 0 ± 0
0.20 1044 1.2 ± 0.9 0.7 ± 0.4
0.40 909 6.8 ± 1.6 1.1 ± 0.6
0.70 869 8.0 ± 1.7 2.1 ± 0.8
1.00 634 14.9 ± 2.6 4.3 ± 1.3
e = 120 MeVa
0.15 1188 1.5 ± 0.6 0.4 ± 0.3
0.30 1437 2.1 ± 0.6 1.0 ± 0.4
0.50 1369 3.6 ± 0.8 2.7 ± 0.7
0.75 1136 6.1 ± 1.2 2.4 ± 0.7
1.00 825 13.8 ± 2.0 3.6 ± 1.0
1.50 357 31.2 ± 4.7 11.1 ± 2.8
2.00 203 61.0 ± 8.6 34.2 ± 6.5
e = 250 MeV
0.25 491 1.9 ± 1.8 3.1 ± 1.3
0.50 536 2.8 ± 1.8 5.3 ± 1.6
0.80 427 5.2 ± 2.3 3.6 ± 1.5
1.20 563 7.6 ± 2.3 5.5 ± 1.6
2.00 325 29.4 ± 5.1 11.1 ± 3.0
e = 800 MeV
0.25 330 0 ± 1.1 2.3 ± 1.4
0.50 609 0 ± 0.8 0.4 ± 0.4
0.80 655 13.8 ± 2.6 5.1 ± 1.4
1.20 561 14.0 ± 2.9 6.0 ± 1.7
2.00 263 35.2 ± 6.2 7.8 ± 2.8
e = 1000 MeV
0.20 231 3.0 ± 2.2 0 ± 0
1.20 321 13.0 ± 3.7 4.3 ± 2.2
3.00 134 87.9 ± 15.1 38.8 ± 10.0
e = 2000 MeV
0.25 330 0.7 ± 1.3 0.8 ± 0.8
0.50 284 9.7 ± 3.2 6.1 ± 2.3
0.80 378 13.5 ± 3.1 3.3 ± 1.5
1.20 538 9.9 ± 2.3 7.4 ± 1.8
2.00 243 46.3 ± 7.0 15.3 ± 4.0
e = 2500 MeV
0.20 1342 1.4 ± 0.5 0.8 ± 0.4
0.40 1127 3.4 ± 0.9 2.1 ± 0.7
0.60 1635 7.6 ± 1.1 2.6 ± 0.6
0.80 218 7.1 ± 2.9 4.7 ± 2.4
1.20 304 24.7 ± 4.6 4.3 ± 1.9
Data represent whole-genome equivalent values with background subtracted.a150 MeV 
protons with 5 cm polyethylene shielding leading to residual energy of 120 MeV.
October 2015 | Volume 5 | Article 2263
George et al. Biological effectiveness of accelerated protons
Frontiers in Oncology | www.frontiersin.org
adding the yields. When two or more painted chromosomes were 
damaged, each was scored separately.
statistical analysis
The frequency of chromosomal aberrations in the painted 
chromosomes was evaluated as the ratio between aberrations 
scored and total cells analyzed. Several studies have indicated 
that the distribution of radiation damage among chromosomes 
is random, and the yield of exchanges measured within the first 
division after exposure is proportional to the DNA content of 
the chromosome analyzed, with some fluctuation of data (26). 
Therefore, the frequencies of exchanges in individual chromo-
somes can be extrapolated to whole-genome equivalents using a 
modified version of the Lucas et al. (27) formula, Fp = 2.05[fp(1−
fp) + fp1fp2 + fp1fp3 + fp2fp3]FG. Fp is the combined frequency 
of exchanges in all painted chromosomes, fp is the fraction of 
the whole genome comprised of the painted chromosomes, fp1, 
fp2, and fp3 are the fractions of the genome for each individual 
chromosome, and FG is the whole-genome aberration frequency. 
Using this formula, the genomic frequency for a male donor was 
estimated as 2.48 times that detected in chromosomes 1, 2, and 4.
Standard errors for aberration frequencies were calculated 
assuming Poisson statistics. Error bars in each figure represent 
SEs of the mean values. The data were modeled assuming 
binomial errors per number of chromosomes analyzed with the 
frequencies of aberrations of various types extrapolated to whole-
genome equivalents as described above.
A weighted linear-quadratic (LQ) or linear (L) regression 
model was used to fit dose–responses for each proton energy, 
and the γ-ray dose–responses. Using the maximum likelihood 
method, the linear and quadratic coefficients α and β in
 Y Y D D= + +0
2α β  
were found for simple, complex, and total exchanges. Estimates 
of RBE were made from the α-coefficient from the acute response 
(21), denoted as RBEγAcute, and from the ratio of initial slopes for 
γ-rays using our previous data (28–30) of low dose and low dose-
rate irradiation, denoted as RBEmax. For estimating a low dose and 
low dose-rate γ-ray component, we combined the data from our 
previous analysis of 0.1  Gy/h with additional data at low doses 
(<0.5 Gy) from the same volunteer used for the proton experiments. 
For complex exchanges, the low dose and dose-rate γ-rays, complex 
exchanges were rare and RBEmax estimates could not be made.
resUlTs
Tables 1 and 2 list the dose–response data for simple and complex-
type chromosome exchanges for each energy of protons, and are 
represented as whole-genome equivalent values with background 
subtracted. The data, plotted in Figure 1, show a high degree of simi-
larity in the dose–response for simple and complex exchanges for all 
proton energies considered. A weighted regression model based on 
the experimental errors was used to estimate α and β values with SEs 
for a linear-quadratic dose–response fit to the data for γ-rays and 
each proton energy. Tables 3–5 show results of this analysis for total 
exchanges, simple exchanges, and complex exchanges respectively. 
Comparison of the α values for acute and low dose rate (LDR) 
γ-rays fits indicates a dose-rate modifier factor of 1.83 and 1.74 for 
total exchanges and simple exchanges, respectively.
The linear (α) coefficients from the dose–response data 
(Tables 3–5) are similar for all energies as determined by either 
the LQ or L weighted regression models. The α values produced 
from the LQ models resulted in somewhat larger SD compared to 
fits from the linear weighted regression model (results not shown). 
RBE values for simple exchanges were slightly less or more than 
unity using the RBEγAcute and RBE max models, respectively. 
TaBle 2 | Dose–response data for chromosome exchanges per 100 
cells induced by 2 and 2.5 geV protons with and without shielding and 
measured in first post irradiation chemically induced Pcc.
Dose (gy) cells 
scored
simple 
exchanges
complex 
exchanges
e = 2000 MeV, no shielding
0.25 330 0.7 ± 1.3 0.8 ± 0.8 
0.50 284 9.7 ± 3.2 6.1 ± 2.3
0.80 378 13.5 ± 3.1 3.3 ± 1.5
1.20 538 9.9 ± 2.3 7.4 ± 1.8
2.00 243 46.3 ± 7.0 15.3 ± 4.0
e = 2000 MeV, 50 g/cm2 aluminum + 10 cm polyethylene
0.25 401 1.3 ± 0.9 0.6 ± 0.6
0.5 1029 4.8 ± 1.1 2.0 ± 0.7
0.8 940 7.7 ± 1.5 1.6 ± 0.7
1.2 709 15.2 ± 2.4 4.4 ± 1.3
2.0 456 28.7 ± 4.0 3.0 ± 1.5
e = 2500 MeV, no shielding
0.20 1342 1.4 ± 0.5 0.8 ± 0.4
0.40 1127 3.4 ± 0.9 2.1 ± 0.7
0.60 1635 7.6 ± 1.1 2.6 ± 0.6
0.80 218 7.1 ± 2.9 4.7 ± 2.4
1.20 304 24.7 ± 4.6 4.3 ± 1.9
e = 2500 MeV, 50 g/cm2 aluminum
0.20 485 1.1 ± 0.8 0.5 ± 0.5
0.40 696 2.2 ± 0.9 0.7 ± 0.5
0.60 629 9.0 ± 1.9 2.5 ± 1.0
0.80 729 8.8 ± 1.8 3.5 ± 1.1
1.2 551 19.1 ± 3.0 9.3 ± 2.1
Dose was measured at the target area for both shielded and unshielded exposures. 
Data represent whole-genome equivalent values with background subtracted.
TaBle 3 | results for parameter estimates of linear-quadratic dose–
response model for total exchanges, and relative biological effectiveness 
(rBe) factors for protons of different energies compared to acute, or low 
dose or low dose-rate γ-rays.
radiation 
type
α (gy−1) β (gy−2) rBeγacute rBemax
γ-Rays 
acute
0.176 ± 0.018 0.119 ± 0.038 – –
γ-Rays LD 0.096 ± 0.01 – – –
Proton, 
5 MeV
0.171 ± 0.018 0.043 ± 0.065 0.98 ± 0.11 1.78 ± 0.19
Proton, 
120 MeVa
0.156 ± 0.016 0.167 ± 0.039 0.89 ± 0.09 1.62 ± 0.16
Proton, 
250 MeV
0.144 ± 0.017 0.05 ± 0.032 0.82 ± 0.1 1.5 ± 0.18
Proton, 
800 MeV
0.153 ± 0.036 0.114 ± 0.064 0.87 ± 0.21 1.59 ± 0.38
Proton, 
1000 MeV
0.219 ± 0.037 0.12 ± 0.043 1.25 ± 0.21 2.27 ± 0.38
Proton, 
2000 MeV
0.201 ± 0.033 0.093 ± 0.067 1.15 ± 0.19 2.09 ± 0.34
Proton, 
2500 MeV
0.184 ± 0.006 0.105 ± 0.01 1.05 ± 0.05 1.91 ± 0.07
a150 MeV protons with 5 cm polyethylene shielding leading to residual energy of 
120 MeV.
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However, a much higher frequency of complex exchanges was 
observed for each proton beam compared to γ-rays resulting in 
RBEs for complex exchanges varied from 2.1 to 4.1, and this led 
to a modest increase the RBEs for total exchanges. A trend toward 
increasing RBEmax values for proton energies of 1 GeV and higher 
was found for simple and total exchanges.
Data for the yield of chromosome exchanges in the shielded 
samples are listed in Table 2 where values are represented as whole-
genome equivalent with background subtracted. The 2.5  GeV 
protons were shielded with 50 g/cm2 of aluminum, and the 2 GeV 
protons were shielded with 50  g/cm2 of aluminum plus 10  cm 
polyethylene. The doses represent the values measures at the target. 
A comparison of shielded and unshielded data shown in Figure 2 
indicates similar dose–responses for the shielded and unshielded 
high-energy proton beams. However, RBEmax values were reduced 
with shielding. For example, RBE values for total exchanges induced 
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FigUre 1 | Dose response curves for simple (a) and complex (B) chromosome exchanges induced by each ion. Error bars indicate SEMs and 
background values have been subtracted for all data.
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by unshielded and shielded 2 GeV protons were 2.09 ± 0.34 and 
1.26 ± 0.11, respectively, and values were 1.91 ± 0.67 and 1.53 ± 0.14 
for unshielded and shielded 2.5 GeV protons, respectively.
DiscUssiOn
The similarity in frequency of simple and complex exchanges over 
a wide range of proton energies found in our experiments suggests 
that decreases in LET with increasing proton energy is balanced 
by the increase in doses from secondary radiation, most notably 
secondary protons and neutrons (3, 31, 32). When the proton LET 
decreases from about 5 keV/μm at 5 MeV to 0.24 keV/μm at the 
highest energy of 2.5 GeV, there is concomitant increase in the 
contribution from nuclear secondaries and their contribution to 
the biological action cross section (3). Details of the beam charac-
teristics for the shielded and unshielded protons used in our study 
are given in Table 6. Neutrons are produced in the absorbers or 
tissue equivalent materials through nuclear reactions by protons 
and other charged particles. Low energy neutrons (<5 MeV) are 
known to have large RBEs for different types of biological damage, 
including late effects (16). For our unshielded proton experiments, 
neutrons produced by the small amount of absorbing material 
present in the NSRL beam-line and biological samples themselves 
are largely high energy and unlikely to have slowed down to the 
more biologically effective neutron energies (<5 MeV). However, 
our experiments comparing shielding to unshielded protons at 
high energies led to similar yields of chromosome exchanges per 
unit dose. This is consistent with previous radiobiology studies 
TaBle 4 | results for parameter estimates of linear-quadratic 
dose–response model for simple exchanges, and relative biological 
effectiveness (rBe) factors for protons of different energies compared to 
acute or low dose or low dose-rate γ-rays.
radiation 
type
α (gy−1) β (gy−2) rBeγacute rBemax
γ-Rays acute 0.157 ± 0.013 0.092 ± 0.027 – –
γ-Rays LD 0.09 ± 0.004 – – –
Proton, 
5 MeV
0.132 ± 0.016 0.031 ± 0.057 0.84 ± 0.1 1.5 ± 0.18
Proton, 
120 MeVa
0.121 ± 0.015 0.137 ± 0.036 0.77 ± 0.1 1.36 ± 0.17
Proton, 
250 MeV
0.088 ± 0.009 0.064 ± 0.017 0.56 ± 0.06 1.0 ± 0.1
Proton, 
800 MeV
0.116 ± 0.028 0.104 ± 0.049 0.73 ± 0.18 1.3 ± 0.31
Proton, 
1000 MeV
0.159 ± 0.02 0.081 ± 0.023 1.01 ± 0.13 1.79 ± 0.23
Proton, 
2000 MeV
0.132 ± 0.028 0.071 ± 0.058 0.84 ± 0.19 1.49 ± 0.31
Proton, 
2500 MeV
0.119 ± 0.01 0.077 ± 0.015 0.76 ± 0.07 1.35 ± 0.11
a150 MeV proton beam with 5 cm polyethylene shielding leading to residual energy of 
120 MeV.
TaBle 5 | results for parameter estimates of linear-quadratic dose–
response model for complex exchanges, and relative biological 
effectiveness (rBe) factors for protons of different energies compared to 
acute γ-rays.
radiation type α (gy−1) β (gy−2) rBeγacute
γ-Rays acute 0.015 ± 0.005 0.025 ± 0.014 –
Proton, 5 MeV 0.039 ± 0.004 0.006 ± 0.017 2.56 ± 0.85
Proton, 120 MeVa 0.032 ± 0.0043 0.024 ± 0.01 2.1 ± 0.28
Proton, 250 MeV 0.055 ± 0.009 0.03 ± 0.017 3.59 ± 1.3
Proton, 800 MeV 0.029 ± 0.010 0.02 ± 0.017 1.92 ± 0.87
Proton, 1000 MeV 0.06 ± 0.016 0.046 ± 0.022 3.96 ± 1.64
Proton, 2000 MeV 0.063 ± 0.009 0.028 ± 0.017 4.12 ± 1.41
Proton, 2500 MeV 0.058 ± 0.006 0.026 ± 0.01 3.81 ± 1.26
RBEmax was not determined because low dose-rate γ-rays have very low induction of 
complex exchanges.
a150 MeV proton beam with 5 cm polyethylene shielding leading to residual energy at 
samples of 120 MeV.
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with high-energy proton beams using very thick absorbers (33) 
and suggests that neutrons are ineffective in producing biological 
damage at high energy (>100 MeV). This observation is readily 
predicted by the mean-free path of neutrons which is generally 
>10 g/cm2 for materials of interest. Because the nuclear absorp-
tion cross sections are similar, secondary particles and target 
fragmentation spectrum produced by protons and neutrons are 
nearly identical for energies above a few hundred megaelectron-
volts. Thus, high-energy protons are biologically more effective 
than neutrons of the same energy per unit fluence because of the 
proton charge state, while high-energy neutrons will have higher 
effectiveness per unit dose.
The NSRL beam-line and the sample holders provide a minimum 
of 1.2  g/cm2 of aluminum equivalent shielding. The additional 
shielding used in our experiments had a minor influence on the 
biological effectiveness when comparing unshielded high-energy 
proton beams because the secondary radiation produced behind the 
shielding will be of similar biological effectiveness as the primary 
TaBle 6 | Details of protons shielding characteristics.
energy at  
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entrance (MeV)
shielding energy of 
beam at 
target (MeV)
leT 
(keV/μm)
Percentage 
of dose from 
secondaries
5 None – 7.80 –
120 5 cm polyethylene 42 0.64 6.4
250 None 220 0.43 17.4
800 None 770 0.24 33.1
1000 None 970 0.22 36.5
2000 None 1924 0.21 42.6
50 g/cm2 
aluminum + 10 cm 
polyethylene
1624 0.21 80.0
2500 None 2470 0.21 43.7
50 g/cm2 
aluminum
2241 0.21 78.4
Shielding from booster window, ion chambers, and binary filter contribute 1.2 g/cm2 of 
aluminum equivalent shielding to all exposures (shielded or unshielded). 
LET reflects values for the beam only and does not include the effect of secondary 
particles.
beam, while similar numbers of low energy target fragments of high-
LET produced for both the primary and secondary protons and 
neutrons will be produced for the shielded and unshielded beams.
The α values for acute and LDR γ-rays fits indicate a dose-
rate modification factor of 1.83 and 1.74 for total exchanges and 
simple exchanges, respectively. These values are similar to those 
reported for dose-rate reduction factors found by Peng et al. (34), 
dose and dose-rate reduction effectiveness factors (DDREF) for 
tumor induction in mice (21), and larger than values reported for 
solid tumors in the atomic bomb survivors where a DDREF of 1.3 
is estimated in the BEIR VII report (35).
In the present study, we used three-color combinations of 
fluorescence in situ hybridization (FISH) chromosome painting 
probes (chromosomes 1, 2, and 4, or 1, 2, and 5) to analyze our 
data. Presumably complex exchanges would be underestimated 
with this method due to the presence of some pseudosimple-type 
exchanges [that is, complex patterns that are indistinguish-
able from those created by simple reciprocal exchanges (36)]. 
Although the true complexity of exchanges can be determined 
only by analysis of all chromosomes, a significant number of 
chromosome exchanges found for all proton energies in this 
study were determined to be complex, which were significantly 
increased compared to acute or low dose-rate γ-rays.
In conclusion, our study of the proton energy dependence 
of chromosome exchanges in human lymphocytes suggests that 
biological effects are similar over a wide range of proton energies 
(5–2500 MeV) with RBE values for total exchanges are close to 
unity when measured against acute γ rays, and approach 2 when 
measured against low dose rate γ rays due to the increased number 
of complex exchanges at all proton energies compared to γ-rays.
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